Loading...
XKRX002630
Market cap142mUSD
Jan 06, Last price  
1,761.00KRW
1D
-1.89%
1Q
282.83%
Jan 2017
-51.40%
Name

Orient Bio Inc

Chart & Performance

D1W1MN
XKRX:002630 chart
P/E
16.22
P/S
7.46
EPS
108.55
Div Yield, %
0.00%
Shrs. gr., 5y
8.85%
Rev. gr., 5y
-1.61%
Revenues
28.01b
-2.82%
22,451,710,00043,857,141,00042,803,189,00044,736,561,00048,171,311,00052,052,582,02076,980,372,44083,722,281,28093,709,381,140105,049,545,520109,019,002,320121,207,763,26030,373,353,89037,699,312,90052,020,405,17026,276,462,48028,819,028,14028,005,127,320
Net income
12.87b
P
526,732,000-4,556,272,000-622,871,000-579,886,0004,066,486,000-10,601,938,550878,817,260-9,550,821,260-1,749,195,210-3,009,261,090-19,126,520,540-13,865,151,000-19,505,949,560-10,880,761,690-15,633,538,12034,198,169,000-12,423,707,81012,871,053,370
CFO
3.76b
+223.86%
1,517,804,000-5,356,962,000-1,859,896,0009,351,273,0003,114,785,000-7,867,483,2005,094,251,3602,169,073,3601,603,027,680912,429,000-4,652,575,000-1,966,434,150-11,539,791,130-4,671,820,9208,739,490,6502,351,249,0001,159,936,9603,756,538,150

Profile

ORIENT BIO Inc. operates in the bio-industry in South Korea. The company produces laboratory animals. In addition, it offers various equipment for research environment. The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005. ORIENT BIO Inc. was founded in 1959 and is based in Seongnam, South Korea.
URL
https://www.orientbio.co.kr/
IPO date
Dec 28, 1976
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
28,005,127
-2.82%
28,819,028
9.68%
26,276,462
-49.49%
Cost of revenue
24,154,185
23,804,263
22,361,815
Unusual Expense (Income)
NOPBT
3,850,943
5,014,765
3,914,648
NOPBT Margin
13.75%
17.40%
14.90%
Operating Taxes
(167,024)
69,125
Tax Rate
1.77%
NOPAT
3,850,943
5,181,789
3,845,523
Net income
12,871,053
-203.60%
(12,423,708)
-136.33%
34,198,169
-318.75%
Dividends
Dividend yield
Proceeds from repurchase of equity
19,765
19,765
BB yield
-0.03%
-0.02%
Debt
Debt current
603,142
679,301
5,466,244
Long-term debt
5,476,280
1,016,202
3,297,162
Deferred revenue
Other long-term liabilities
5,248,506
5,597,112
6,189,700
Net debt
(53,739,027)
(10,775,836)
(29,598,781)
Cash flow
Cash from operating activities
3,756,538
1,159,937
2,351,249
CAPEX
(925,250)
(485,641)
(2,210,723)
Cash from investing activities
(3,115,861)
(20,657,857)
16,770,333
Cash from financing activities
(570,353)
(6,791,812)
(1,133,981)
FCF
(1,337,809)
350,259
22,672,862
Balance
Cash
41,227,628
35,466,307
59,043,708
Long term investments
18,590,821
(22,994,967)
(20,681,520)
Excess cash
58,418,193
11,030,389
37,048,365
Stockholders' equity
75,398,946
62,568,850
74,364,501
Invested Capital
34,966,004
66,806,833
59,725,776
ROIC
7.57%
8.19%
7.19%
ROCE
4.12%
6.44%
4.05%
EV
Common stock shares outstanding
118,568
118,568
118,582
Price
598.00
-3.08%
617.00
-33.30%
925.00
-41.46%
Market cap
70,903,739
-3.08%
73,156,534
-33.31%
109,688,737
-38.69%
EV
17,164,713
62,380,698
80,090,227
EBITDA
6,534,678
8,104,890
7,840,217
EV/EBITDA
2.63
7.70
10.22
Interest
56,900
252,282
432,885
Interest/NOPBT
1.48%
5.03%
11.06%